Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Share News (AGY)

Share Price Information for Allergy Thera. (AGY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.25
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.50 (10.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.25
AGY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK shareholder meetings calendar - next 7 days

Mon, 15th Nov 2021 16:05

Tuesday 16 November 
Craneware PLCAGM
Dunelm Group PLCAGM
James Halstead PLCAGM
New Star Investment Trust PLCAGM
Wednesday 17 November 
AMTE Power PLCAGM
Berkeley Energia LtdAGM
BMO Real Estate Investments LtdAGM
Caribbean Investment Holdings LtdGM re delisting from AIM
Celtic PLCAGM
Henderson Eurotrust PLCAGM
Ncondezi Energy LtdAGM
Pacific Horizon Investment Trust PLCAGM
Picton Property Income LtdAGM
Rainbow Rare Earths LtdAGM
Smiths Group PLCAGM
Smiths Group PLCGM re sale of Smiths Medical
Thursday 18 November 
Avast PLCGM re takeover by NortonLifeLock
Avingtrans PLCAGM
Close Brothers Group PLCAGM
Eagle Eye Solutions Group PLCAGM
Finsbury Food Group PLCAGM
FirstGroup PLCGM re tender offer
Fonix Mobile PLCAGM
FW Thorpe PLCAGM
IronRidge Resources LtdAGM re gold demerger, name change
James Halstead PLCAGM
JD Wetherspoon PLCAGM
Litigation Capital Management LtdAGM
Maestrano Group PLCAGM
Omni Egis PLCGM - re cancellation of AQSE listing
Panthera Resources PLCAGM
President Energy PLCGM re dividend in specie of shares in Atome Energy
Friday 19 November 
Blue Prism Group PLCGM re Bali Bidco takeover
Diurnal Group PLCAGM
eEnergy Group PLCAGM
KCR Residential REIT PLCAGM
Kier Group PLCAGM
Marble Point Loan Financing LtdAGM
Petra Diamonds LtdAGM
Starcom PLCGM re name change, share consolidation
Monday 22 November 
Allergy Therapeutics PLCAGM
Crystal Amber Fund LtdAGM
Mila Resources PLCGM re placing, subscription and buy of Kathleen Valley stake
Mountview Estates PLCGM re director re-appointments
Norish PLCEGM re name change, share subdivision and change in articles of association
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
1 Dec 2020 16:06

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
20 Nov 2020 14:51

UK DIRECTOR DEALINGS SUMMARY: Landsec CEO Buys GBP300,000 Worth

UK DIRECTOR DEALINGS SUMMARY: Landsec CEO Buys GBP300,000 Worth

Read more
26 Oct 2020 14:17

IN BRIEF: Allergy Therapeutics Kicks Off Grass Allergy Therapy Study

IN BRIEF: Allergy Therapeutics Kicks Off Grass Allergy Therapy Study

Read more
26 Oct 2020 13:37

Allergy Therapeutics screens first patients in grass pollen study

(Sharecast News) - Commercial biotechnology company Allergy Therapeutics announced the screening of the first patient in its exploratory field study 'G309', to evaluate the efficacy and safety of 'Grass MATA MPL' in subjects with seasonal allergic rhinitis or rhinoconjunctivitis induced by grass pollen exposure.

Read more
23 Sep 2020 14:02

UK EARNINGS SUMMARY: LoopUp Swings To Profit On Work-From-Home Boost

UK EARNINGS SUMMARY: LoopUp Swings To Profit On Work-From-Home Boost

Read more
4 Sep 2020 19:39

IN BRIEF: Allergy Therapeutics Secures VLP Technology Platform

IN BRIEF: Allergy Therapeutics Secures VLP Technology Platform

Read more
3 Sep 2020 15:31

Allergy Therapeutics signs new vaccine deal with Saliba and DeepVax

(Sharecast News) - Biotechnology company Allergy Therapeutics announced further investment in virus-like particle (VLP) technology for applications beyond the allergy immunotherapy field on Thursday.

Read more
15 Jul 2020 11:47

UK TRADING UPDATE SUMMARY: Finsbury Food's Annual Revenue Set To Fall

UK TRADING UPDATE SUMMARY: Finsbury Food's Annual Revenue Set To Fall

Read more
15 Jul 2020 09:03

Allergy Therapeutics revenues grow despite Covid-19 disruption

(Sharecast News) - Biotechnology company Allergy Therapeutics reported a "strong" full-year performance on Wednesday despite challenges stemming from the Covid-19 pandemic.

Read more
9 Jul 2020 21:19

IN BRIEF: Allergy Therapeutics To Recommence Birch B301 Trial

IN BRIEF: Allergy Therapeutics To Recommence Birch B301 Trial

Read more
9 Jul 2020 16:26

Allergy Therapeutics pleased with invalidation of B301 trial data

(Sharecast News) - Biotechnology company Allergy Therapeutics announced the outcome of scientific advice from the German Regulatory Authority, the Paul Ehrlich Institute (PEI), over invalidation of the primary endpoint data of the Birch MATA MPL pivotal phase 3 clinical trial, or 'B301', on Thursday.

Read more
24 Jun 2020 11:53

Allergy Therapeutics Anticipates Profit Ahead Of Expectations

Allergy Therapeutics Anticipates Profit Ahead Of Expectations

Read more
24 Jun 2020 10:12

Allergy Therapeutics on track to 'significantly' exceed FY expectations

(Sharecast News) - Biotechnology company Allergy Therapeutics said on Wednesday that its 2020 trading performance was on track to exceed market expectations.

Read more
4 Mar 2020 10:46

Allergy Therapeutics Well-Placed Despite Regulatory "Challenge"

Allergy Therapeutics Well-Placed Despite Regulatory "Challenge"

Read more
26 Feb 2020 16:15

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.